{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:13:59Z","timestamp":1783646039896,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473063"],"award-info":[{"award-number":["82473063"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172348"],"award-info":[{"award-number":["82172348"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cca.2026.121053","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:33:37Z","timestamp":1777995217000},"page":"121053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Serial monitoring of cytokine profile, liver function, and hematological biomarkers in severe CRS and CLS following CAR-T cell therapy for relapsed hepatocellular carcinoma: a case report"],"prefix":"10.1016","volume":"590","author":[{"given":"Minle","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixiu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.cca.2026.121053_bb0005","doi-asserted-by":"crossref","first-page":"16247","DOI":"10.1007\/s00432-023-05367-w","article-title":"Constitutive photomorphogenic protein 1 ubiquitinates interleukin-1 receptor accessory protein in human liver cancer","volume":"149","author":"Cao","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.cca.2026.121053_bb0010","article-title":"Conversion of primary liver cancer after targeted therapy for liver cancer combined with AFP-targeted CAR T-cell therapy: a case report","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.cca.2026.121053_bb0015","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.xkme.2021.06.011","article-title":"Collapsing focal segmental glomerulosclerosis and acute kidney injury associated with chimeric antigen receptor T-cell (CAR-T) therapy: a case report","volume":"3","author":"Acharya","year":"2021","journal-title":"Kidney Medicine"},{"issue":"1","key":"10.1016\/j.cca.2026.121053_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-020-00193-5","article-title":"Successful treatment of acute B lymphoblastic leukemia relapse in the skin and testicle by anti-CD19 CAR-T with IL-6 knocking down: a case report","volume":"8","author":"Liu","year":"2020","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.cca.2026.121053_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-020-00216-1","article-title":"Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed\/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report","volume":"8","author":"Li","year":"2020","journal-title":"Biomark. Res."},{"issue":"11","key":"10.1016\/j.cca.2026.121053_bb0030","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010080","article-title":"Uncommon biphasic CAR-T expansion induces hemophagocytic lymphohistiocytosis-like syndrome and fatal multiple infections following BCMA CAR-T cell therapy: a case report","volume":"12","author":"Yan","year":"2024","journal-title":"J. Immunother. Cancer."},{"key":"10.1016\/j.cca.2026.121053_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1257491","article-title":"Case report: catastrophic event: neonatal gastric perforation and complication of capillary leak syndrome","volume":"11","author":"Li","year":"2023","journal-title":"Front. Pediatr."},{"issue":"2","key":"10.1016\/j.cca.2026.121053_bb0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL clinical practice guidelines on the management of hepatocellular carcinoma","volume":"82","author":"Sangro","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cca.2026.121053_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119704","article-title":"Very unusual extremely high ferritin with cytokine release syndrome in a patient with hematological malignancy after experimental chimeric antigen receptor (CAR)\u2013T-cell therapy","volume":"559","author":"Hoyt","year":"2024","journal-title":"Clin. Chim. Acta"},{"issue":"8","key":"10.1016\/j.cca.2026.121053_bb0050","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.ymthe.2023.06.006","article-title":"Two cases of severe pulmonary toxicity from highly active mesothelin-directed CAR T cells","volume":"31","author":"Haas","year":"2023","journal-title":"Mol. Ther."},{"issue":"15","key":"10.1016\/j.cca.2026.121053_bb0055","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1158\/1078-0432.CCR-19-3259","article-title":"Chimeric antigen receptor-Glypican-3 T-cell therapy for advanced hepatocellular carcinoma: results of phase I trials","volume":"26","author":"Shi","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cca.2026.121053_bb0060","article-title":"Long term complete response of advanced hepatocellular carcinoma to glypican-3 specific chimeric antigen receptor T-cells plus sorafenib, a case report","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cca.2026.121053_bb0065","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3324\/haematol.2022.281059","article-title":"IL1RAP is expressed in several subtypes of pediatric acute lymphoblastic leukemia and can be used as a target to eliminate ETV6::RUNX1-positive leukemia cells in preclinical models","volume":"108","author":"\u00c5gerstam","year":"2023","journal-title":"Haematologica (Roma)"},{"issue":"1","key":"10.1016\/j.cca.2026.121053_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-024-01586-x","article-title":"IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cells","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.cca.2026.121053_bb0075","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.3324\/haematol.2020.254987","article-title":"The IL1-IL1RAP axis plays an important role in the inflammatory leukemic niche that favors acute myeloid leukemia proliferation over normal hematopoiesis","volume":"106","author":"De Boer","year":"2021","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.cca.2026.121053_bb0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40259-018-0324-z","article-title":"Mechanisms and Management of Chimeric Antigen Receptor T-cell therapy-related toxicities","volume":"33","author":"Dholaria","year":"2019","journal-title":"BioDrugs"},{"issue":"1","key":"10.1016\/j.cca.2026.121053_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-024-00573-9","article-title":"New insights into CAR T-cell hematological toxicities: manifestations, mechanisms, and effective management strategies","volume":"13","author":"Yang","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2026.121053_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-38723-y","article-title":"Neutralizing IFN\u03b3 improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies","volume":"14","author":"Manni","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2026.121053_bb0095","article-title":"Association of AST\/ALT ratio with 90-day outcomes in patients with acute exacerbation of chronic liver disease: a prospective multicenter cohort study in China","volume":"11","author":"Liu","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.cca.2026.121053_bb0100","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2147\/CIA.S303629","article-title":"Dynamic changes in liver function tests and their correlation with illness severity and mortality in patients with COVID-19: a retrospective cohort study","volume":"16","author":"Xu","year":"2021","journal-title":"Clin. Interv. Aging"},{"issue":"2","key":"10.1016\/j.cca.2026.121053_bb0105","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/CCM.0000000000002053","article-title":"Cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukemia","volume":"45","author":"Fitzgerald","year":"2017","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.cca.2026.121053_bb0110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41392-025-02178-y","article-title":"Deep insight into cytokine storm: from pathogenesis to treatment","volume":"10","author":"Nie","year":"2025","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:31:59Z","timestamp":1783643519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126002354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":22,"alternative-id":["S0009898126002354"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121053","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serial monitoring of cytokine profile, liver function, and hematological biomarkers in severe CRS and CLS following CAR-T cell therapy for relapsed hepatocellular carcinoma: a case report","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121053"}}